These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20716632)

  • 1. Molecular alterations associated with sulindac-resistant colon tumors in ApcMin/+ mice.
    Greenspan EJ; Nichols FC; Rosenberg DW
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1187-97. PubMed ID: 20716632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice.
    McEntee MF; Chiu CH; Whelan J
    Carcinogenesis; 1999 Apr; 20(4):635-40. PubMed ID: 10223192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC.
    Faux MC; Weinstock J; Gogos S; Prato E; Azimpour AI; O'Keefe R; Cathcart-King Y; Garnham AL; Ernst M; Preaudet A; Christie M; Putoczki TL; Buchert M; Burgess AW
    Cancer Res Commun; 2022 Feb; 2(2):66-77. PubMed ID: 36860494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.
    Yang K; Fan K; Kurihara N; Shinozaki H; Rigas B; Augenlicht L; Kopelovich L; Edelmann W; Kucherlapati R; Lipkin M
    Carcinogenesis; 2003 Mar; 24(3):605-11. PubMed ID: 12663524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations.
    Itano O; Yang K; Fan K; Kurihara N; Shinozaki H; Abe S; Jin B; Gravaghi C; Edelmann W; Augenlicht L; Kopelovich L; Kucherlapati R; Lamprecht S; Lipkin M
    Carcinogenesis; 2009 Nov; 30(11):1923-6. PubMed ID: 19755659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
    Williamson T; Bai RY; Staedtke V; Huso D; Riggins GJ
    Oncotarget; 2016 Oct; 7(42):68571-68584. PubMed ID: 27612418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis.
    Greening DW; Ji H; Kapp EA; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2293-307. PubMed ID: 23899461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer.
    Zimmers TA; Gutierrez JC; Koniaris LG
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):571-6. PubMed ID: 19784846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo.
    Yang W; Velcich A; Mariadason J; Nicholas C; Corner G; Houston M; Edelmann W; Kucherlapati R; Holt PR; Augenlicht LH
    Cancer Res; 2001 Aug; 61(16):6297-302. PubMed ID: 11507085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition.
    Tinsley HN; Gary BD; Thaiparambil J; Li N; Lu W; Li Y; Maxuitenko YY; Keeton AB; Piazza GA
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1303-13. PubMed ID: 20876730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
    Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
    Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs.
    Leibowitz B; Qiu W; Buchanan ME; Zou F; Vernon P; Moyer MP; Yin XM; Schoen RE; Yu J; Zhang L
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16520-5. PubMed ID: 25368155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression.
    Ritland SR; Gendler SJ
    Carcinogenesis; 1999 Jan; 20(1):51-8. PubMed ID: 9934849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
    Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J
    Cancer Res; 2002 Jan; 62(2):403-8. PubMed ID: 11809688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.
    Hinoi T; Akyol A; Theisen BK; Ferguson DO; Greenson JK; Williams BO; Cho KR; Fearon ER
    Cancer Res; 2007 Oct; 67(20):9721-30. PubMed ID: 17942902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
    Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
    J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice.
    Pan P; W Skaer C; Wang HT; Oshima K; Huang YW; Yu J; Zhang J; M Yearsley M; A Agle K; R Drobyski W; Chen X; Wang LS
    Carcinogenesis; 2017 Jan; 38(1):86-93. PubMed ID: 27866157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
    Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.